Quick Answer
Vivani Medical, Inc. reported Total Revenue of $7.96 million for fiscal year 2017.
Vivani Medical, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | — | — | — | — | — | — |
| Net Income | -$26.61M -13.3% |
-$23.49M +8.4% |
-$25.65M -84.7% |
-$13.89M -8.7% |
-$12.77M +14.2% |
-$14.88M +55.7% |
| Diluted EPS | -$0.43 +0.0% |
-$0.43 +14.0% |
-$0.50 | — | — | — |
| Total Assets | $39.39M -5.2% |
$41.56M -9.2% |
$45.80M -10.4% |
$51.13M +837.6% |
$5.45M +22.3% |
$4.46M -73.1% |
| Cash and Equivalents | $16.23M -11.6% |
$18.35M -11.1% |
$20.65M -54.2% |
$45.08M -35.2% |
$69.59M +2090.5% |
$3.18M -72.0% |
| Stockholders Equity | $15.73M -10.7% |
$17.61M -15.2% |
$20.76M -53.1% |
$44.31M +1697.5% |
$2.46M +26.4% |
$1.95M -73.2% |
| R&D Expense | $18.13M +15.1% |
$15.74M -7.2% |
$16.97M +19.8% |
$14.17M +28.8% |
$11.00M +127.5% |
$4.84M -63.2% |
| Operating Income | -$27.56M -11.7% |
-$24.68M +8.5% |
-$26.96M -26.9% |
-$21.24M -59.4% |
-$13.32M +10.6% |
-$14.90M +56.1% |
| Gross Profit | — | — | — | — | $130.0K -74.0% |
$500.0K -59.3% |
| Shares Outstanding | 76.43M +29.0% |
59.23M +16.1% |
51.03M +100481.4% |
50,736 -99.9% |
36.80M +158438.0% |
23,214 -99.9% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | March 31, 2018 | $976.0K | -3.3% | -39.4% |
| Net Income | September 30, 2025 | -$6.53M | -8.1% | +8.6% |
| Diluted EPS | September 30, 2025 | -$0.11 | +0.0% | +8.3% |
| Total Assets | September 30, 2025 | $25.05M | -41.6% | -13.4% |
| Cash and Equivalents | September 30, 2025 | $2.63M | -86.6% | -61.3% |
| Stockholders Equity | September 30, 2025 | $1.31M | -92.9% | -73.3% |
| R&D Expense | September 30, 2025 | $4.52M | +7.5% | -5.0% |
| Operating Income | September 30, 2025 | -$6.72M | -6.6% | +9.9% |
| Gross Profit | June 30, 2021 | $0.00 | — | — |
| Shares Outstanding | September 30, 2025 | 61.51M | +11.3% | +3.8% |
- Vivani Medical, Inc. reported Total Revenue of $7.96 million for fiscal year 2017.
- Vivani Medical, Inc. showed an increase of +99.8% in Total Revenue compared to the prior fiscal year.
- Vivani Medical, Inc. reported Net Income of -$26.61 million for fiscal year 2025.
- Vivani Medical, Inc. showed a decrease of -13.3% in Net Income compared to the prior fiscal year.
- Vivani Medical, Inc. reported Diluted EPS of $0.43 per share (loss) for fiscal year 2025.
- Vivani Medical, Inc. showed an increase of +0.0% in Diluted EPS compared to the prior fiscal year.
- Vivani Medical, Inc. reported Total Assets of $39.39 million for fiscal year 2025.
- Vivani Medical, Inc. showed a decrease of -5.2% in Total Assets compared to the prior fiscal year.
- Vivani Medical, Inc. reported Cash and Equivalents of $16.23 million for fiscal year 2025.
- Vivani Medical, Inc. showed a decrease of -11.6% in Cash and Equivalents compared to the prior fiscal year.
- Vivani Medical, Inc. reported Stockholders Equity of $15.73 million for fiscal year 2025.
- Vivani Medical, Inc. showed a decrease of -10.7% in Stockholders Equity compared to the prior fiscal year.
- Vivani Medical, Inc. reported R&D Expense of $18.13 million for fiscal year 2025.
- Vivani Medical, Inc. showed an increase of +15.1% in R&D Expense compared to the prior fiscal year.
- Vivani Medical, Inc. reported Operating Income of -$27.56 million for fiscal year 2025.
- Vivani Medical, Inc. showed a decrease of -11.7% in Operating Income compared to the prior fiscal year.
- Vivani Medical, Inc. reported Gross Profit of $130.0 thousand for fiscal year 2021.
- Vivani Medical, Inc. showed a decrease of -74.0% in Gross Profit compared to the prior fiscal year.
- Vivani Medical, Inc. reported Shares Outstanding of 76.43 million shares for fiscal year 2025.
- Vivani Medical, Inc. showed an increase of +29.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: